good luck on your next stock, since you are out of this one now.. I am long 100,000 shares of XXII and holding this one. Party just begun. Drop by around Cristmas and see where we are >>>
Every company always promotes positive news. I wouldn't call it 'spin' as that implies some dubious claims. When in fact, all the prior studies have shown how VLN content results in better smoking cessation rates. I think the PR supports $4 but long term I think we see $8-12, but if no buy out suitors...could go to $40.
"I just finished watching the Hatsukami talk from the conference where she described the results of the Donny study. “Immediate” reduction of nicotine was more effective in helping people reduce their smoking, although “immediate” (unsurprisingly) was more difficult for smokers. She also thanked XXII at the end for providing the research cigs."
Will be used by... 1. Company: more effective in helping people reduce their smoking 2. BT: “immediate” (unsurprisingly) was more difficult for smokers. i.e they will smoke more to get nicotine fix, therefore ingesting more tars and carcinogens
...we will see what the market believes will prevail ... BT will have to come over to FDA side for XXII to have real traction.
"PEER" conclusions of study will be pivotal ... which side will they fall on?
News 
Market Data 
Discover 
